Definium Therapeutics, Inc. (DFTX)
22.39
+0.64
(+2.94%)
USD |
NASDAQ |
May 05, 16:00
22.42
+0.03
(+0.13%)
After-Hours: 20:00
Definium Therapeutics Market Cap : 2.232B for May 5, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Atai Beckley, Inc. | 1.464B |
| Plus Therapeutics, Inc. | 42.92M |
| Viridian Therapeutics, Inc. | 1.924B |
| Nutriband, Inc. | 50.08M |
| Immunovant, Inc. | 5.663B |
Market Cap Related Metrics
| PEG Ratio | -1.270 |
| Price to Book Value | 6.717 |
| Price | 22.39 |
| Earnings Yield | -9.24% |
| PEGY Ratio | -1.270 |